Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit)

v3.26.1
Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($)
Common Shares
January 2026 PIPE
Common Shares
Additional Paid-in Capital
January 2026 PIPE
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
January 2026 PIPE
Total
Balance at the beginning at Dec. 31, 2024       $ 107,546,433 $ (371,184) $ (90,687,073)   $ 16,488,176
Balance at the beginning (in shares) at Dec. 31, 2024   1,307,568            
Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit)                
Share-based compensation expense       457,310       457,310
Re-measurement of liability-classified C$ stock options       136,868       136,868
Net loss           (17,464,932)   (17,464,932)
Balance at the end at Jun. 30, 2025       108,140,611 (371,184) (108,152,005)   (382,578)
Balance at the end (in shares) at Jun. 30, 2025   1,307,568            
Balance at the beginning at Dec. 31, 2024       107,546,433 (371,184) (90,687,073)   16,488,176
Balance at the beginning (in shares) at Dec. 31, 2024   1,307,568            
Balance at the end at Dec. 31, 2025       129,518,812 (371,184) (130,406,220)   (1,258,592)
Balance at the end (in shares) at Dec. 31, 2025   2,152,397            
Balance at the beginning at Mar. 31, 2025       107,877,891 (371,184) (98,034,976)   9,471,731
Balance at the beginning (in shares) at Mar. 31, 2025   1,307,568            
Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit)                
Share-based compensation expense       212,015       212,015
Re-measurement of liability-classified C$ stock options       50,705       50,705
Net loss           (10,117,029)   (10,117,029)
Balance at the end at Jun. 30, 2025       108,140,611 (371,184) (108,152,005)   (382,578)
Balance at the end (in shares) at Jun. 30, 2025   1,307,568            
Balance at the beginning at Dec. 31, 2025       129,518,812 (371,184) (130,406,220)   (1,258,592)
Balance at the beginning (in shares) at Dec. 31, 2025   2,152,397            
Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit)                
Share-based compensation expense       598,319       598,319
Proceeds from issuance of Common Shares, pre-funded warrants, and warrants from January 29, 2026 PIPE, net of issuance costs     $ 70,081,309       $ 70,081,309  
Proceeds from issuance of Common Shares, pre-funded warrants, and warrants from January 29, 2026 PIPE, net of issuance costs (in shares) 6,815,296              
Re-measurement of liability-classified C$ stock options       (48,073)       (48,073)
Net loss           (19,974,029)   (19,974,029)
Balance at the end at Jun. 30, 2026       200,150,367 (371,184) (150,380,249)   49,398,934
Balance at the end (in shares) at Jun. 30, 2026   8,967,693            
Balance at the beginning at Mar. 31, 2026       199,739,348 (371,184) (138,650,593)   60,717,571
Balance at the beginning (in shares) at Mar. 31, 2026   8,967,693            
Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit)                
Share-based compensation expense       408,895       408,895
Re-measurement of liability-classified C$ stock options       2,124       2,124
Net loss           (11,729,656)   (11,729,656)
Balance at the end at Jun. 30, 2026       $ 200,150,367 $ (371,184) $ (150,380,249)   $ 49,398,934
Balance at the end (in shares) at Jun. 30, 2026   8,967,693